PKNOX1 and metabolic dysfunction-associated steatotic liver disease: And it has been validated that Pknox1 as a target of both miR‐17 and miR‐19a in a previous study on mixed lineage leukemia.22 However, the hepatic miR‐19 level was slightly altered in the rat model of T2DM/NAFLD (Figure S2C).